This is the text extract for November Tender Notification, browse documents here.

---

30 November 2009

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 11th December 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2008/09 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to listed pharmaceuticals where no other brand is listed – Sole Subsidised Supply commences on 1 April 2010.

The decisions were as follows:

Chemical Name Tropisetron

Presentation; Pack size and type Cap 5 mg; 5 capsules, blister

Current Subsidy $77.41

New tender subsidy $77.41

Sole supply brand (Supplier) Navoban (Novartis)

2. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 January 2010, reference pricing of nontender winning brand will occur on 1 March 2010 and Sole Subsidised Supply commences on 1 June 2010.

The decisions were as follows:

Chemical Name Flucloxacillin sodium* Flucloxacillin sodium* Paracetamol with codeine Pindolol* Pindolol* Pindolol*

Presentation; Pack size and type Cap 250 mg; 250 capsules, bottle Cap 500 mg; 500 capsules, bottle Tab paracetamol 500 mg with codeine phosphate 8 mg; 100 tablets, blister Tab 5 mg; 100 tablets, bottle Tab 10 mg; 100 tablets, bottle Tab 15 mg; 100 tablets, bottle

Current subsidy $18.50 $57.90 $3.24 $4.50 $8.35 $12.00

New tender subsidy $32.00 $110.00 $2.45 $5.40 $9.19

Sole supply brand (Supplier) AFT (AFT) AFT (AFT) ParaCode (Arrow) Apo-Pindolol (Apotex) Apo-Pindolol (Apotex)

Brands affected by reference pricing and delisting Staphlex (Mylan) Staphlex (Mylan) Codalgin (Sigma) Pindol (Mylan) Pindol (Mylan) Pindol (Mylan)

$13.80 Apo-Pindolol (Apotex)

*Reference pricing will not be applied

A303174 - qA12214

---

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 3. Tenders awarded to listed pharmaceuticals where only the current brand is listed – DV Limits and DV Pharmaceuticals will apply from 1 March 2010.

The decisions were as follows:

Chemical Name Tropisetron

Presentation; Pack size and type Cap 5 mg; 5 capsules, blister

Hospital Supply Brand (Supplier) Navoban (Novartis)

Pack Price $77.41

DV Limit 1%

DV Pharmaceuticals Brand Name (Supplier) (B)

4. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 January 2010; DV Limits and DV pharmaceuticals will apply from 1 March 2010; de-listing of other brands in Section H will occur on 1 March 2010.

The decisions were as follows:

Chemical Name Flucloxacillin sodium Flucloxacillin sodium

Presentation; Pack size and type Cap 250 mg; 250 capsules, bottle Cap 500 mg; 500 capsules, bottle

Hospital Supply Brand (Supplier) AFT (AFT) AFT (AFT)

Pack Price $32.00 $110.00

DV Limit 1% 1%

DV Pharmaceuticals Brand Name (Supplier) Staphlex (Mylan) Staphlex (Mylan)

5. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 January 2010 and DV Limits and DV Pharmaceuticals will apply from 1 March 2010.

The decisions were as follows:

Chemical Name Pindolol Pindolol Pindolol

Presentation; Pack size and type Tab 5 mg; 100 tablets, bottle Tab 10 mg; 100 tablets, bottle Tab 15 mg; 100 tablets, bottle

Hospital Supply Brand (Supplier) Apo-Pindolol (Apotex) Apo-Pindolol (Apotex) Apo-Pindolol (Apotex)

Pack Price $5.40 $9.19 $13.80

DV Limit 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) Pindol (Mylan) Pindol (Mylan) Pindol (Mylan)

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 23 December 2008.

The decisions were as follows:

Chemical Name Aciclovir Aciclovir Aciclovir Aciclovir Aciclovir Aciclovir Diclofenac Sodium Diclofenac Sodium Hydrocortisone with Miconazole Leflunomide Leflunomide

Line Item Tab 200 mg Tab 400 mg Tab 800 mg Tab dispersible 200 mg Tab dispersible 400 mg Tab dispersible 800 mg Tab long-acting 75 mg Tab long-acting 100 mg Crm 1% with miconazole nitrate 2% Tab 10 mg Tab 20 mg

A303174 - qA12214

Page 2 of 3

---

Chemical Name Leflunomide Mucilaginous Laxatives Mupirocin Tropisetron

Line Item Tab 100 mg Sugar Free Oint 2% Inj 1 mg per ml, 2 ml

2007/08 Tender Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 21 December 2007.

The decisions were as follows:

Chemical Name Ceftriaxone Sodium Ceftriaxone Sodium Ceftriaxone Sodium Dexamethasone Dexamethasone Dexamethasone Dexamethasone Gentamicin Sulphate Hydrocortisone Butyrate Tamsulosin Tobramycin

Line Item Inj 500 mg Inj 1 g Inf 2 g Eye drops 0.1% Tab 0.5 mg Tab 1 mg Tab 4 mg Powder BP Crm 0.1% (pack size greater than 30 g) Tab 400 mcg Powder BP

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A303174 - qA12214

Page 3 of 3